Registry of Irreversible Electroporation for the Ablation of Prostate Cancer With Use of Nanoknife Device
The aim of this registry is to assess the recurrence of prostate cancer at 1 and 5 years, as well as the change in functional outcomes (e.g. incontinence or erectile function) from baseline. Secondary objectives are to establish which indications lead to treatment with IRE Nanoknife® setting and safety assessment measured by number of complications and adverse events.
|Study start date||2014-09-26|